LUNG
Pulmonx CorporationPre-market1.76−0.04 −2.22%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delay
Open
1.79
Prev close
1.80
Day range
1.751.87
52-week range
1.132.89
Volume
498.61K1.03×
Mkt cap
75.59M
P/E ttm
—
Fwd P/E
-1.87
EPS ttm
-1.15
Div yield
0.00%
Earnings
Oct 27, 2026
From 52w high
−39.10%
LUNG compared with peers
LUNG vs Peers
5 peers · related companies in the same sector
Forward P/E
−1.9×
peer median —
EV/EBITDA
−1.7×
peer median 0.2×
Price / sales
0.9×
peer median 9.8×· 91% discount
Net margin
−55.0%
peer median −175.8%· +120.8 pts
Revenue growth
−4.6%
peer median 2.8%· −7.4 pts
Comparison
| Company | Mkt cap | Today | Fwd P/E | P/E | PEG | P/S | P/B | EV/EBITDA | EV/Sales | Div yield | Remove |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LUNGPulmonx Corporation | 75.59M | −2.2% | −1.9× | — | — | 0.9× | 1.9× | −1.7× | 0.9× | 0.0% | |
| STTKShattuck Labs, Inc. | 550.99M | −9.9% | −10.6× | — | — | 551.0× | 2.6× | −6.6× | 345.4× | 0.0% | |
| CCCCC4 Therapeutics, Inc. | 342.01M | −9.2% | −2.9× | — | — | 9.8× | 1.4× | −1.5× | 4.1× | 0.0% | |
| PRLDPrelude Therapeutics Incorporat | 284.10M | −4.8% | −6.5× | — | — | 12.7× | 2.7× | −3.6× | 10.4× | 0.0% | |
| FHTXFoghorn Therapeutics Inc. | 109.86M | −5.1% | −1.8× | — | — | 3.0× | — | 0.2× | −0.4× | 0.0% | |
| OMOutset Medical, Inc. | 76.32M | 1.2% | −1.8× | — | — | 0.6× | 0.8× | −0.5× | 0.3× | 0.0% | |
| Peer median | 284.10M | −5.1% | — | — | — | 9.8× | 2.0× | 0.2× | 7.3× | 0.0% |
Positioning
Bubble size is market cap. A name above the cluster costs more for the same growth or margin.